The IBM on demand facility will provide variable peakload compute capacity to respond to requirements beyond the capabilities of EOS' in-house systems. Such requirements may include, for example, analysis of clinical trial data, the preparation of documentation for the FDA, and validation of ongoing product enhancements.
EOS is a medical technology company that designs and develops light-based computer vision systems for the early detection of epithelial cancers and other tissue diseases.
"MelaFind's computer vision can outperform human vision in clinical detection of melanoma", stated Dr. Marek Elbaum, CEO, Electro-Optical Sciences. "Adding the supercomputing power allows us to rapidly train the statistical pattern recognition algorithms that we use to differentiate images of melanoma from benign look-alike lesions in order to render a reliable and objective diagnosis."
The EOS technology has been applied to the detection of early melanoma, the early detection of tooth decay, for chronic wound management, and it has potential applications for the early detection of other cancers. "The on demand computing model helps allow customers to avoid technological risk as well as the financial risk associated with ownership", stated David Turek, vice president, IBM Deep Computing. "Deep computing on demand is designed to fulfil those two goals, freeing customers to focus on growing their business."
With deep computing on demand customers can:
- help avoid large IT capital outlays and long term depreciation or lease schedules. This is especially important for companies with short term projects.
- bring to bear, on a temporary basis, massive amounts of compute power that could be otherwise unaffordable and which helps provide strategic insight
- help lower overall operating costs
- help improve price/performance for compute-intensive applications and processing of massive amounts of data
- off-load certain system maintenance to IBM
- use the latest technologies to help maximize performance
- meet the urgent computational needs of new business opportunities that could otherwise be cost-prohibitive